Tirzepatide vs Semaglutide: Which Is Better for Weight Loss?

Price comparison for Tirzepatide vs Semaglutide might be obvious, but people get confused when they have to figure out which one is safer and more effective.

These drugs belong to a class called GLP-1 receptor agonists that work by mimicking a hormone your gut naturally releases after you eat. Glucagon-like peptide-1 (GLP-1), does two things: it tells your pancreas to produce more insulin, and it signals your brain that you’re full. You feel less hungry, which encourages weight loss.

Semaglutide mimics GLP-1 alone. It’s sold under three brand names: Ozempic and Rybelsus for type 2 diabetes, and Wegovy, specifically approved for weight management.

Tirzepatide mimics two hormones simultaneously. Both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) drive insulin production and satiety signals. It has been approved as Mounjaro for diabetes and Zepbound for weight loss.

We have reviewed the reliable GLP-1 providers in the market on the basis of cost, how they work, dosage administration, effectiveness, side effects, and user experiences. This comparison should help you decide which GLP-1 provider works best for weight loss.

Tirzepatide vs Semaglutide – Key Differences 

Category	Semaglutide (Ozempic® /Wegovy®/Rybelsus®)	Tirzepatide (Mounjaro® /Zepbound®)
How it works	Targets one hormone (GLP-1) to reduce hunger and slow digestion	Targets two hormones (GLP-1 + GIP) for a stronger hunger-suppressing effect
Average weight loss	12–15% of body weight	17–22% of body weight
Administration	Weekly injection or daily oral tablet (Rybelsus®)	Weekly injection only
Monthly cost (no insurance)	$982–$1,325	$495–$1,062
FDA approved for weight loss	Wegovy® (adults + teens 12+)	Zepbound® (adults only)
FDA approved for diabetes	Ozempic® & Rybelsus®	Mounjaro®
Side effects	Nausea, vomiting, diarrhea (generally milder)	Same side effects, may be stronger at higher doses
Safety warning	Possible risk of thyroid tumors	Possible risk of thyroid tumors
Safe for kids	Wegovy® approved for ages 12+	Not approved for children
Special cases	Also approved for MASH (liver disease) in 2025	Also approved for obstructive sleep apnea (OSA) in adults with obesity
Best for	People who want heart/kidney protection, prefer a pill, or are treating a teen	People who want maximum weight loss or also have sleep apnea or high blood sugar

What Are Tirzepatide?

Tirzepatide works by targeting two hunger-related hormones in your body (GLP-1 and GIP). This dual action helps you feel full faster and lose more weight over time.

Most GLP-1 medications only target one hormone. Tirzepatide targets both, which is why the results are stronger.

The FDA approved it twice. First in 2022 as Mounjaro® for type 2 diabetes, then in 2023 as Zepbound® specifically for weight loss.

• Mounjaro®:  for managing type 2 diabetes
• Zepbound®:  for chronic weight management

Clinical trials showed an average weight loss of 17–22% of body weight, making it one of the most effective options currently available.

If you’re exploring tirzepatide, check out our picks for the best tirzepatide providers to find a plan that fits your needs.

What Are Semaglutide?

Semaglutide targets one hormone (GLP-1) to help reduce your appetite, control blood sugar, and support consistent weight loss.

It’s been in the market longer than tirzepatide, so more doctors are familiar with it, and it has a stronger track record overall.

The FDA has approved it under three brand names, each for a different purpose:

• Ozempic®: for type 2 diabetes (approved 2017)
• Wegovy®: for weight loss in adults and teens 12+ (approved 2021)
• Rybelsus®: an oral tablet option for type 2 diabetes

Rybelsus® is currently the only oral GLP-1 option available. 

People using semaglutide lose 12–15% of their body weight. It’s not as high as tirzepatide, but for many people it’s more than enough, especially when combined with the added heart and kidney benefits.

Take a look at our top picks for the best semaglutide providers to find a program that suits your goals.

Tirzepatide vs Semaglutide – How Do They Work? 

The main difference between the two drugs is in how many hormones they target. Both medications reduce hunger and improve blood sugar. As a result, users can effectively lose weight. But the mechanism differs significantly. 

Tirzepatide 

Tirzepatide activates two hormone receptors in your body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Both are released naturally after you eat, and both play a direct role in controlling hunger and blood sugar.

Here is what happens when tirzepatide activates both:

• Your pancreas releases insulin when your blood sugar rises after a meal, preventing spikes
• Your liver produces less sugar, keeping blood sugar stable throughout the day
• Digestion slows down, so you feel full faster and stay full longer
• GIP receptor activation further suppresses hunger and supports fat metabolism. This is what gives tirzepatide an edge over single-hormone medications

Mounjaro® is the tirzepatide brand approved for type 2 diabetes. Zepbound® is approved for chronic weight management and is also the only GLP-1 medication currently approved for treating obstructive sleep apnea in adults with obesity.

Semaglutide 

Semaglutide activates one hormone receptor: GLP-1. This is the same receptor tirzepatide targets, which is why the two medications share several similarities in how they feel and what side effects they produce.

Here is what GLP-1 activation does:

• Your pancreas releases insulin after meals, keeping blood sugar levels controlled
• Your liver reduces its sugar output, helping maintain steadier blood sugar between meals
• Digestion slows, and appetite decreases, so most people feel satisfied with smaller portions

Ozempic® is approved for type 2 diabetes and carries additional FDA approval for reducing the risk of heart attack, stroke, and cardiovascular death. Wegovy® is approved for weight loss in adults and teenagers aged 12 and older. Rybelsus® is the only oral GLP-1 option approved for type 2 diabetes.

Tirzepatide vs Semaglutide – Price and Insurance Policies 

Cost is one of the biggest factors people consider when choosing between these two medications. Both are expensive without insurance, and most insurance plans won’t cover them for weight loss. 

Coverage is more likely if you have type 2 diabetes.

What You’ll Pay Without Insurance:

Medication	Brand Name Cost	Manufacturer Program	Compounded Cost
Tirzepatide	$1,000–$1,400/mo	LillyDirect: $349 (starter), then $499/mo	$200–$450/mo
Semaglutide	$900–$1,200/mo	NovoCare: $499/mo	$200–$400/mo

Brand name through a retail pharmacy is the most expensive route. You’re paying full price unless your insurance covers it.

Manufacturer savings programs like  Eli Lilly (tirzepatide) and Novo Nordisk (semaglutide) offer direct savings programs. LillyDirect starts at $349/month for new patients. NovoCare offers a flat $499/month rate. These are worth checking before assuming you can’t afford the brand name.

Compounded versions through a telehealth provider offer the biggest savings. Compounded tirzepatide and semaglutide are made by licensed U.S. pharmacies and can cost as little as $200/month. Many telehealth programs bundle the medication, prescription, and ongoing support into one monthly price.

What about Tirzepatide vs Semaglutide With Insurance?

Semaglutide has been in the market for longer, so some insurance plans offer partial coverage, particularly for Ozempic® when prescribed for diabetes. Wegovy® for weight loss is harder to get covered.

Tirzepatide is newer, so insurance coverage for weight loss is even more limited. Mounjaro® may be covered for diabetes, but Zepbound® coverage varies widely by plan.

Tirzepatide vs Semaglutide – Dosage and Administration Schedule 

Both medications are taken once a week as a small injection under the skin, and both follow a step-by-step schedule that gradually increases over several months. Titration gives your body time to adjust and helps reduce side effects like nausea early on.

Tirzepatide Dosage Schedule (Zepbound® for Weight Loss)

Tirzepatide has six steps and reaches a higher maximum dose. The doses are larger because it works on two hormone receptors rather than one.

Stage	Weekly Dose	Timeframe
Starting dose	2.5 mg	Weeks 1–4
Step 2	5 mg	Weeks 5–8
Step 3	7.5 mg	Weeks 9–12
Step 4	10 mg	Weeks 13–16
Step 5	12.5 mg	Weeks 17–20
Maintenance dose	15 mg	Week 21 onward

Many people start noticing stronger appetite suppression once they reach the 5–10 mg range. The full 15 mg dose is where the most significant weight loss occurs. 

Semaglutide Dosage Schedule (Wegovy® for Weight Loss)

Semaglutide has five steps over roughly four months before reaching the full maintenance dose.

Stage	Weekly Dose	Timeframe
Starting dose	0.25 mg	Weeks 1–4
Step 2	0.5 mg	Weeks 5–8
Step 3	1 mg	Weeks 9–12
Step 4	1.7 mg	Weeks 13–16
Maintenance dose	2.4 mg	Week 17 onward

Semaglutide can cause nausea, bloating, and digestive discomfort, especially early on so the dosage is increased slowly. 

Note: Ozempic® follows a different dosing schedule since it is prescribed for diabetes, not weight loss.

Is Tirzepatide Better Than Semaglutide For Weight Loss?

Both medications work well and produce effective weight loss. 

Tirzepatide was tested in the SURMOUNT-1 trial over 72 weeks. People on the highest dose lost 20–22.5% of their body weight. That is close to what some people achieve with weight loss surgery.

Semaglutide was tested in the STEP-1 trial over 68 weeks. People on the full dose lost 14–15% of their body weight. That is still a significant result, and semaglutide has more long-term safety data behind it than tirzepatide does.

The weight loss gap between the two is significant. For someone who weighs 250 lbs, tirzepatide could mean losing 55 lbs versus 37 lbs with semaglutide. That is an 18 lb difference from the same type of weekly injection.

Tirzepatide can cause stronger digestive side effects at higher doses. Semaglutide is generally easier on the stomach, especially in the first few weeks. Semaglutide also has FDA approval for heart and kidney protection, while tirzepatide does not.

If your main goal is maximum weight loss, tirzepatide has stronger results. If you have heart or kidney concerns or want a medication with a longer track record, semaglutide is the more well-rounded option.

Tirzepatide vs Semaglutide – Side Effects

Both medications cause similar side effects since they work through the same GLP-1 pathway, and slowing digestion is what makes them effective for weight loss. That same mechanism is also what causes most of the discomfort.

The most common side effects for both include:

• Nausea
• Bloating or gas
• Constipation
• Diarrhea
• Vomiting
• Stomach pain
• Fatigue

Most people experience these during the first few weeks or after each dose increase. For the majority, symptoms are mild and settle down as the body adjusts.

Tirzepatide tends to cause more nausea and digestive discomfort early on, particularly as the dose increases. Going slower on dose increases can help manage this.

Semaglutide is generally easier to tolerate in the early weeks, which is one reason some doctors prefer it as a starting point for people who are sensitive to digestive side effects.

Both medications carry the same boxed warning for a possible risk of thyroid tumors. This was observed in animal studies. Neither medication is recommended for people with a personal or family history of certain thyroid conditions.

Note: If side effects feel unmanageable at any point, talk to your provider before stopping. Adjusting your dose schedule is often enough to get things back on track.

Tirzepatide vs Semaglutide – Real User Reviews 

Tirzepatide holds an average rating of 8.5 out of 10 from nearly 3,000 reviews online, with 78% of users reporting a positive experience.

Here is what real users have shared:

“I was a size 22 and am now almost a size 10. My BMI went from 39 to just over 30. I lost 45 pounds. I am no longer taking medication for migraines, asthma, and chronic edema.” – Drugs.com

“Thank you Zepbound for showing me what being full was. It’s a whole new feeling. Four weeks in, over 20 pounds lost.” – Drugs.com

Not all experiences are smooth though. Some users find the higher doses harder to manage:

“After going to 7.5 mg, the dizziness, stomach pains, and diarrhea became too much. I lost 37 pounds but had to stop.” 

Semaglutide users describe a steadier experience but the results speak for themselves:

“From the moment I took the first injection, the food noise was gone. I have been on Wegovy for almost 7 weeks and have lost over 22 lbs.” – Drugs.com

“I started at a size XXL and 213 lbs. After a little over a year, I am now 125 lbs and a size small. This drug literally reset my entire body chemistry.” – Drugs.com

“This medication worked for me and helped me lose over 60 lbs. In the past I tried numerous diets, supplements, bariatric surgery, and all failed. This is the only thing that truly worked.” – Drugs.com

Some users do flag side effects when increasing doses too quickly:

“Tried 1.0 mg and it was too strong – nausea and painful stomach cramps. I went back to 0.50 mg, reached my goal weight, and lost 35 pounds. Very happy with the results.” – Drugs.com

Tirzepatide users report faster appetite suppression and bigger numbers on the scale. Semaglutide users describe a gentler start with a steadier pace but meaningful results either way. The difference is mostly in speed and tolerance, not in whether they work.

Which One Should You Choose?

It depends on what your body needs and what your health goals are. But we can help you make that decision clearer.

Tirzepatide targets two hormones instead of one. Most people on tirzepatide lose 20–22% of their body weight compared to 14–15% with semaglutide. For someone weighing 250 lbs, that gap is nearly 20 lbs.

Beyond the scale, tirzepatide also tends to work faster. Many users report noticeable appetite suppression within the first one to two weeks.

It is also a strong choice if you have insulin resistance, prediabetes, or metabolic syndrome. The dual GIP and GLP-1 action gives your body stronger blood sugar support than semaglutide alone can offer.

Tirzepatide may be the right fit if you:

• Want the highest possible weight loss results
• Have struggled to lose weight with other medications
• Also deal with high blood sugar or insulin resistance
• Have obesity-related sleep apnea

Semaglutide has been around longer, which means more real-world data, more doctors familiar with it, and a broader set of FDA approvals. It is FDA-approved to reduce the risk of heart attack and stroke.

It is also generally easier to tolerate, especially in the early weeks. If you are sensitive to digestive side effects, semaglutide tends to cause less discomfort at equivalent doses.

Semaglutide may be the right fit if you:

• Have a history of heart disease or are at cardiovascular risk
• Have chronic kidney disease
• Prefer a medication with a longer safety track record
• Want an oral option (Rybelsus® is the only GLP-1 pill currently available)
• Are treating a teenager (Wegovy® is approved for ages 12 and up)

When Should You Consider Switching?

If you are on semaglutide and not seeing the results you expected, switching to tirzepatide is an option. 

You may benefit from switching: 

• if your weight loss has stalled at higher semaglutide doses, 
• if you have insulin resistance or a high A1C that needs stronger support, 
• or if you simply want more aggressive results. 

Switching is generally safe when done under medical supervision. Your provider will help you time the transition, pick the right starting dose, and manage any side effects along the way. In most cases, you will not need to restart from the lowest dose.

However, switching is not always the right move. 

If you are already losing weight steadily or prefer a gentler experience, staying on semaglutide makes more sense. Semaglutide has FDA approvals for heart and kidney protection that tirzepatide does not yet have, and for many people, that matters more than faster weight loss.

Both tirzepatide and semaglutide are effective, and the right choice comes down to your goals and your health history. If you are ready to move forward, explore our top-rated GLP-1 providers to find a plan that fits your goals and your budget.